Joshua A Kazam is a director of Kronos Bio Inc.
Person profile
Roles
Address
New York, New York
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Kronos Bio, Inc.
29 Jun 22
4
Allogene Therapeutics, Inc.
17 Jun 22
4
Allogene Therapeutics, Inc.
9 Mar 22
4
Kronos Bio, Inc.
9 Mar 22
4
Allogene Therapeutics, Inc.
14 Jan 22
3
Screaming Eagle Acquisition Corp.
6 Jan 22
4
Kronos Bio, Inc.
23 Jun 21
4
Allogene Therapeutics, Inc.
11 Jun 21
4
TS Innovation Acquisitions Corp.
7 Jun 21
3
Soaring Eagle Acquisition Corp.
23 Feb 21
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 Jun 22 | KRON Kronos Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 3.53 | 34,000 | 120.02 k | 34,000 |
| 15 Jun 22 | ALLO Allogene Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 44,178 | 0.00 | 303,063 |
| 7 Mar 22 | ALLO Allogene Therapeutics | Common Stock | Gift | Dispose G | No | No | 0 | 412,618 | 0.00 | 258,885 |
| 7 Mar 22 | ALLO Allogene Therapeutics | Common Stock | Other | Acquire J | No | No | 0 | 412,618 | 0.00 | 671,503 |
| 12 Jan 22 | ALLO Allogene Therapeutics | Common Stock | Buy | Acquire P | No | No | 12.6 | 15,000 | 189.00 k | 258,885 |